We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

Design and biological evaluation of synthetic retinoids : probing length vs. stability vs. activity.

Clemens, G. and Flower, K. R. and Gardner, P. and Henderson, A. P. and Knowles, J. P. and Marder, T. B. and Whiting, A. and Przyborski, S. A. (2013) 'Design and biological evaluation of synthetic retinoids : probing length vs. stability vs. activity.', Molecular bioSystems., 9 (12). pp. 3124-3134.


All trans-retinoic acid (ATRA) is widely used to direct the differentiation of cultured stem cells. When exposed to the pluripotent human embryonal carcinoma (EC) stem cell line,, ATRA induces ectoderm differentiation and the formation of neuronal cell types. We report in this study that novel polyene chain length analogues of ATRA require a specific chain length to elicit a biological responses of the EC cells, with synthetic retinoid AH61 being particularly active, and indeed more so than ATRA. The impacts of both the synthetic retinoid AH61 and natural ATRA on the cells were directly compared using both RT-PCR and Fourier Transform Infrared Micro-Spectroscopy (FT-IRMS) coupled with multivariate analysis. Analytical results produced from this study also confirmed that the synthetic retinoid AH61 had biological activity comparable or greater than that of ATRA. In addition to this, AH61 has the added advantage of greater compound stability than ATRA, therefore, avoiding issues of oxidation or decomposition during use with embryonic stem cells.

Item Type:Article
Full text:(AM) Accepted Manuscript
Download PDF
Publisher Web site:
Date accepted:No date available
Date deposited:22 May 2014
Date of first online publication:December 2013
Date first made open access:No date available

Save or Share this output

Look up in GoogleScholar